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ABSTRACT 
The PTPN22 gene plays vital role in T1D onset by encoding Lymphoid-specific phosphatase 
(LYP) that lead to T-cell receptor-associated CsK kinase inactivation and preventing T-cell 
spontaneous activation by dephosphorylation. VDR gene encoded for VDR receptor is involved 
indirectly in prevention of T1D onset by promoting insulin production. The present study was 
conducted to determine the mutations on rs2476601 and rs1544410 polymorphic sites on the 
PTPN22 and VDR genes respectively. We genotyped 50 patients and 50 control subjects from 
Lahore by using sequencing and Polymerase Chain Reaction-Restriction Fragment Length 
Polymorphism (RFLP) techniques. It was observed that the allelic frequency of r and b were 
higher in patients as compared to controls and significantly associated with the onset of T1D. 
The genotype distribution frequencies varied significantly among patients and controls (p < 
0.01). The mutation on the rs2476601 polymorphic site led to the change of Isoleucine to 
tryptophan in patients. In conclusion, compelling evidence was found of T1D onset association 
with the polymorphism at RsaI on rs2476601 and BsmI on rs1544410 on PTPN22 and VDR 
genes.  
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INTRODUCTION 
The autoimmune destruction of β-cells caused by genetic susceptibility leads to the development 
of a complex disorder named as Type 1 Diabetes mellitus (T1D) (Pociot and Mcdermott, 2002). 
Although the genetic association of T1D was reported in various populations, major 
Histocompatibility Complex (MHC), Insulin (INS) and Cytotoxic T Lymphocyte Associated 
Protein 4 (CTLA4) genes were confirmed in several independent studies (Undlien et al., 2001; 
Anjos et al., 2004) 
Polymorphism in PTPN22 and VDR genes are an important predictor of T1D. PTPN22 is located 
on the short arm of chromosome 1 near telomere (1p.13.2). It contained 57,898 bases and 
encodes a protein (lymphoid-specific phosphatase) of 807 amino acids with 91705 Da Molecular 
weight (Presscott et al., 2005; Vang et al., 2007).  Tyrosine phosphatase expressed primarily in 
lymphoid tissues and was reported to be involved in several signaling pathways associated with 
the immune response (Bottini et al., 2004). PTPN22 specifically expressed in lymphocytes and 
through the formation of a complex with C-terminal Src Kinase (CSK) suppressed the 
downstream mediators of T-cell receptor signaling (Cloutier et al., 1996). VDR is highly 
polymorphic and is located on 12 q chromosome (12-12q14) (Stene et al., 2000). Vitamin D 
performed an immunosuppression and inhibited the production of cytokine and immunoglobulin 
and the activation of lymphocyte (Sandler et al., 1994). Therefore, infants who have vitamin D 
intake in early childhood have a lower incidence of T1DM in adulthood (Dalquist et al., 1999). 
Several SNPs potentially contribute to susceptibility to T1D and among them, rs2476601 on 
PTPN22 and rs1544410 on VDR were most reported SNP (Ban et al., 2001; Dharia et al., 2011). 
Single-nucleotide polymorphism (rs2476601, A/G) located on exon 14 resulted in arginine (R) 
substitution by tryptophan (W) at LYP codon 620 (R620W) and showed greater T-cell receptor 
signaling inhibition (Begovich et al., 2004). In the rs1544410, A/G is located on Intron 8 of VDR 
gene, but its function is still not clearly understood (Uitterlinden et al., 2204) 
T1D is a disease affecting children, especially the young Pakistani population because of 
common intracaste marriages that made a narrow genetic pool. The reported cases of T1D are 
increasing with the passage of time throughout the world, as well as in Pakistan. Therefore, the 
present study was conducted to evaluate the strength of PTPN22 and VDR polymorphisms in 
Pakistani Youngsters with T1D. 
MATERIAL AND METHOD 
Subjects 
Blood samples were collected after informed consent from 50 T1D and 50 healthy control 
subjects. Patients and controls were age and sex matched. The current study was approved by the 
Board of Studies at GC University, Lahore and the Ethical Committee of Shalamar Hospital, 
Lahore. The patients the participated in the current study were diagnosed with T1D below 10 
years of age and depended on insulin treatment from the time of diagnosis. 
DNA Isolation and Genotyping 
DNA was isolated from each sample through the modified organic method (Sambrook et al., 
1989). The SNPs were selected on the basis of the SNP reported associated with T1D in various 
populations. PCR of the region with the polymorphic site (rs2476601) was performed by using 
F.P: ACCAGCTTCCTCAACCACAA and R.P: AGAATTTCCTTTGGATTGTT and the 
polymorphic site (rs1544410) by using F.P: CAACCAAGACTACAAGTACCGCGTCAGTGA 
and R.P: AACCAGCGGGAAGAGGTCAAGGG. The PCR conditions were as follows: initial 
denaturation (95ºC for 5 min), then 35 cycles with following temperature profile: denaturation 
(95ºC for 45 sec), annealing (rs2476601: 63.4ºC and rs1544410: 55.9ºC for 30 sec), extension 
(68ºC for 45 sec), and final elongation for 10 min.   
Restriction Fragment Length Polymorphism (RFLP)  
The PCR products of rs2476601 (218 bp) and rs1544410 (825 bp) were digested with RsaI and 
65ºC respectively at 37ºC for 3h and then subjected to 2% agarose gel electrophoresis. The PCR 
Products were sent to ABI (Korea) for sequencing to determine the genotype. The sequences 
were visualized using BioEdit software. 
Statistical Analysis 
Hardy-Weinberg equilibrium was determined using Transposer software.8. Allelic and 
Genotypic associations of both SNPs was tested by using the Fisher exact test through online 
SHEsis software (http://analysis.bio-x.cn/SHEsisMain.htm). Changes in Amino Acid Alignment 
were determined using MEGA6 Software. 
 
 
RESULTS 
A total of 50 T1D patients participated. The mean age was 18, with 12 years in males and 20.21 
years in Females. All patients had a positive maternal and paternal family history of T1D. On the 
Other hand, the mean age of males and female controls was 17.41 years and 19.91 years 
respectively with a negative family history of T1D. The mean concentration of isolated DNA 
samples were 50 ng/µl and quality (260/280 value) 1.8 shown in Figure 1. 
 
Figure 1: DNA isolated from P (Patients) blood sample. 
The PTPN22 and VDR gene polymorphisms (R/r and B/b) were assigned in the patients and 
controls respectively by using the PCR-RFLP method. It was observed that the Digestion of the 
PCR product with RsaI and BsmI endonuclease enzyme produced three different sized bands, i.e. 
218bp, 176bp, 42bp and 825bp, 650bp, 175bp respectively shown in Figure 2 and 3. 
 
 
 
 
 
 
 
 
Figure 2: RFLP of PTPN22 (rs2476601) on 2% agarose gel. (a) Patients. Lanes 1-3 and 5-6 
shows homozygous genotype (rr) with 176bp and 42bp and Lane 4 shows heterozygous 
genotype with 218bp, 176bp and 42bp (Rr). (b) Controls: Lanes 1-3 shows homozygous 
genotype with 218bp (RR). 
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Figure 3: RFLP of VDR (rs1544410) on 2% agarose gel. (a) Patients. Lanes 1-2 shows 
heterozygous genotype (Bb) with 825bp, 650bp and 175bp. Lane 3 shows homozygous genotype 
with 825bp (BB) and Lane 4 shows homozygous genotype with 650bp and 175bp (bb). (b) 
Controls: Lanes 1, and 4 shows homozygous genotype with 825bp (BB) and Lane 3 shows 
heterozygous genotype with 825bp, 650bp and 175bp (Bb). 
RsaI and BsmI polymorphisms did not deviate from Hardy Weinberg equilibrium (p > 0.05). The 
frequency of r and b alleles was higher in patients as compared to controls (Table 1). The 
genotype distribution frequencies vary significantly among patients and controls (p < 0.01). The 
rr, Rr, bb and Bb genotype occurred more frequently in patients, whereas RR and BB were more 
common in controls (Table 2). Therefore, it was found that the onset of T1D was significantly 
associated with the polymorphism at RsaI on rs2476601 and BsmI on rs1544410. 
Table 1: Allele frequency with T1D in patients and controls. 
Gene SNP No Alleles Patients: n 
Control: 
n p-value 
PTPN22 rs2476601 R 2 98 0.002** R 92 8 
VDR rs1544410 B 38 100 0.015* B 62 0 
*represent p < 0.05 and ** represents p < 0.01 
  
Table 2: Genotype frequency with T1D in patients and controls. 
Gene SNP No Genotype Patients: n (%) 
Controls: 
n (%) X
2 p-value df (2) 
PTPN22 rs2476601 
Rr 44 (88) 0 (0) 
86.98 0.002** Rr 4 (8) 2 (4) 
RR 2 (4) 48 (96) 
VDR rs1544410 
Bb 15 (30) 0 (0) 
88.67 0.011* Bb 32 (64) 1 (2) 
BB 3 (6) 49 (98) 
*represent p < 0.05, ** represents p < 0.01, R = A, r = G, B = A, b =  G 
b 
b 
a 
The rr and bb genotype conferred a higher risk for type 1 diabetes with an odds ratio of 10.42 
[95% confidence interval: 11.6±27.2] for rr and 6.41 [95% confidence interval: 4.54±8.94] for 
bb. 
By using BioEdit software, sequences were visualized and genotype was shown in Figure 4. 
The alignment of DNA sequences of patients on the MEGA-6 software showed that a change in 
the nucleotide on the rs2476601 polymorphic site lead to the change of Isoleucine tryptophan 
(Figure 5). 
 
Figure 4: Chromatographic representation of rs2476601 (a) Patient Genotype (GG) (b). Control 
Genotype (AA) and rs1544410 (c) Patient Genotype (GA) (d). Control Genotype (AA). 
 
 
 
 
Figure 5: Change in Nucleotide (Cytosine into Thymine) lead to the change of amino acid 
sequence (Isoleucine into Tryptophan). 
DISCUSSION 
The current study demonstrated that PTPN22 and VDR gene polymorphism was associated with 
T1D onset in Pakistani population. In human genomes, single nucleotide polymorphisms (SNPs) 
are common and that provides evidence for specific genes involvement in the onset of human 
diseases. A genetic variant that appears in at least 1 % of the population is called a 
polymorphism. Alteration in the gene regulatory parts could affect the gene expression level, and 
lead ultimately to the level of proteins (Vilarino et al., 2011). Genetics plays a vital role in the 
early onset and progression of the disease (Gyrus, E. 2012). Insulin secretion is influenced by the 
Vitamin D hormone, as well as PTPN22.  
The current study confirmed the significant association of rs2476601 with T1D that results in a 
substitution of arginine (R) by tryptophan (W) residue at LYP codon 620(R620W) with the 
tryptophan variant showing greater inhibition of T-cell receptor signaling. A study conducted by 
Chelala et al. (2007) supported that rs2476601 was the major risk determinant at PTPN22 for 
T1D onset. Recently, Maah et al. (2014) showed evidence that the PTPN22 C1858T variant 
regulates type 1 diabetes–specific autoimmunity and strongly affects the progression from 
preclinical to clinical diabetes. 
Allelic frequencies of r and b were higher in patients as compared to control subjects. Similarly, 
polymorphisms within the VDR gene that may modify T1D susceptibility were reported in 
Southern Indian subjects through the transmission disequilibrium test (McDermott et al., 1997). 
McDermott et al. (1997) reported that allele ‘b’ of BsmI was found frequently in affected 
subjects. In line with the present study, polymorphism on BsmI is present in intron 7 of VDR 
gene and therefore, no direct change is expected in the coding sequences. Hence, the BsmI 
polymorphism role on the susceptibility to T1D remained unknown. Farrow (1994) and Barker et 
al. (1988), reported that the regulation of protein synthesis might be mediated by especially 
elongated 30 untranslated regions in the VDR gene of mRNA that ultimately lead to the change 
in the gene expression of stability of mRNA. Some groups tried to relate stability and levels of 
VDR mRNA to VDR genotypes and reported that the stability of VDR mRNA was not 
influenced by polymorphism within the VDR 30 untranslated region (Verbeek et al., 1997). 
CONCLUSION 
In conclusion, the present study demonstrates that T1D is a chronic disorder affecting the health 
of young adults and causing huge losses to Pakistani society. Polymorphism at the rs2476601 
and rs1544410 site on PTPN22 and VDR gene respectively are significantly associated with the 
onset of T1D in Pakistan. A large scale systematic survey is required to get the clearer picture of 
disease and the genetic susceptibility of a population.  
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